Global LFA-based Cardiac Marker Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global LFA-based Cardiac Marker market size was valued at US$ 3950 million in 2024 and is forecast to a readjusted size of USD 5970 million by 2031 with a CAGR of 6.5% during review period.

LFA-based Cardiac Marker is a cardiac marker test based on lateral flow chromatography technology. Lateral flow chromatography technology is a detection method based on the principle of paper chromatography. It is widely used in the detection of disease biomarkers, especially in line with the World Health Organization's REASSURED principle in clinical testing, that is, reasonable cost, high sensitivity, strong specificity, convenient operation, fast and stable, no need for special equipment, easy promotion, real-time feedback, easy sampling, and environmentally friendly. Cardiac markers refer to proteins or enzymes that are released into the peripheral blood and detected during the course of heart disease. They can reflect changes in the structure or function of the heart. Cardiac marker detection based on lateral flow chromatography technology uses the advantages of lateral flow chromatography technology to quickly, accurately and conveniently detect cardiac markers to meet the clinical needs for immediate detection of heart disease.

Market Drivers

Rising Prevalence of Cardiovascular Diseases:

The prevalence of cardiovascular diseases is increasing globally, especially in low- and middle-income countries. This has led to an increase in demand for cardiac marker testing, as cardiac marker testing plays an important role in early diagnosis, risk assessment, and treatment monitoring of heart disease.

Technological Advances and Cost Reductions:

With the advancement of science and technology, the sensitivity and specificity of lateral flow chromatography technology has continued to improve, while the cost of testing has gradually decreased. This has made cardiac marker testing based on lateral flow chromatography technology more popular and acceptable, further driving the development of the market.

Growing Demand for Home Testing:

Home testing (also known as self-testing) allows users to test self-collected samples and obtain results without the assistance of trained medical professionals. This testing method plays an important role in cardiovascular diseases and infectious diseases. With the improvement of consumers' health awareness and the popularity of home testing products, the demand for cardiac marker home testing products based on lateral flow chromatography technology is also increasing.

Support from policies and regulations:

The policy support of governments for medical health and technological innovation has provided a good policy environment for the development of the cardiac marker testing market based on lateral flow chromatography technology. For example, the government may introduce relevant policies to encourage innovation, reduce testing costs, and improve testing accuracy, thereby promoting the development of the market.

Population aging and increased medical needs:

As the global population ages, the elderly population's demand for medical and health services continues to increase. Heart disease is one of the common chronic diseases among the elderly, so the application prospects of cardiac marker detection based on lateral flow chromatography technology in the elderly population are broad.

In summary, the development of the cardiac marker detection market based on lateral flow chromatography technology is driven by a variety of factors, including the increase in the prevalence of cardiovascular diseases, technological advances and cost reductions, the growth of home testing needs, policy and regulatory support, and the aging population and increased medical needs. These factors have jointly promoted the rapid development and widespread application of the market.

This report is a detailed and comprehensive analysis for global LFA-based Cardiac Marker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global LFA-based Cardiac Marker market size and forecasts, in consumption value ($ Million), 2020-2031

Global LFA-based Cardiac Marker market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global LFA-based Cardiac Marker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global LFA-based Cardiac Marker market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for LFA-based Cardiac Marker

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global LFA-based Cardiac Marker market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

LFA-based Cardiac Marker market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Troponin
CK-MB
Myoglobin
Others

Market segment by Application
Laboratory Testing
Point-of-care Testing

Market segment by players, this report covers
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe LFA-based Cardiac Marker product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of LFA-based Cardiac Marker, with revenue, gross margin, and global market share of LFA-based Cardiac Marker from 2020 to 2025.

Chapter 3, the LFA-based Cardiac Marker competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and LFA-based Cardiac Marker market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of LFA-based Cardiac Marker.

Chapter 13, to describe LFA-based Cardiac Marker research findings and conclusion.